Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Michael Wagner, Md

Clinical trials sponsored by Michael Wagner, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug BTX-A51 tested in rare sarcomas Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New drug BTX-A51 tested in rare sarcomas

Disease control Ongoing

This early study tests an oral drug called BTX-A51 in 24 people with advanced liposarcoma (a type of fat tissue cancer) that has spread or come back. The main goal is to see if the drug is safe and tolerable at different doses. It focuses on specific genetic subtypes: MDM2-amplif…

Phase 1 • Sponsor: Michael Wagner, MD • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC